Randomized Controlled Trials as Topic
"Randomized Controlled Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.
Descriptor ID |
D016032
|
MeSH Number(s) |
E05.318.760.250.500.365.500 N05.715.360.775.088.500.387.500 N06.850.520.450.250.250.365.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Randomized Controlled Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Randomized Controlled Trials as Topic".
This graph shows the total number of publications written about "Randomized Controlled Trials as Topic" by people in this website by year, and whether "Randomized Controlled Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2002 | 1 | 5 | 6 |
2003 | 4 | 12 | 16 |
2004 | 0 | 15 | 15 |
2005 | 0 | 20 | 20 |
2006 | 3 | 16 | 19 |
2007 | 2 | 10 | 12 |
2008 | 1 | 16 | 17 |
2009 | 2 | 14 | 16 |
2010 | 2 | 15 | 17 |
2011 | 3 | 6 | 9 |
2012 | 4 | 12 | 16 |
2013 | 1 | 5 | 6 |
2014 | 1 | 6 | 7 |
2015 | 1 | 6 | 7 |
2016 | 0 | 7 | 7 |
2017 | 1 | 7 | 8 |
2018 | 1 | 3 | 4 |
2019 | 2 | 5 | 7 |
2020 | 0 | 1 | 1 |
2021 | 0 | 8 | 8 |
2022 | 0 | 8 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Randomized Controlled Trials as Topic" by people in Profiles.
-
Lipton RB, Singh RBH, Revicki DA, Zhao S, Shewale AR, Lateiner JE, Dodick DW. Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials. J Headache Pain. 2022 Apr 25; 23(1):50.
-
Rodriguez RM, O'Laughlin K, Eucker SA, Chang AM, Rising KL, Nichol G, Pauley A, Kanzaria H, Gentsch AT, Li C, Duber H, Butler J, Eswaran V, Glidden D. PROmotion of COvid-19 VA(X)ccination in the Emergency Department-PROCOVAXED: study protocol for a cluster randomized controlled trial. Trials. 2022 Apr 21; 23(1):332.
-
Zhang R, Lai M, Wang D. Psychologic Impacts on Diabetic Neuropathic Pain. Curr Pain Headache Rep. 2022 Jun; 26(6):423-427.
-
Dodick DW, Goadsby PJ, Ashina M, Tassorelli C, Hundemer HP, Bardos JN, Wenzel Md R, Kemmer P, Conley R, Martinez JM, Oakes T. Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review. Headache. 2022 04; 62(4):453-472.
-
Medrea I, Christie S, Tepper SJ, Thavorn K, Hutton B. Network meta-analysis of therapies for cluster headache: Effects of acute therapies for episodic and chronic cluster. Headache. 2022 04; 62(4):482-511.
-
Angarita AM, Jayakumaran J, Di Mascio D, Berghella V. Prophylactic negative pressure wound therapy on wound complications after cesarean delivery in women with obesity: a meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2022 May; 4(3):100617.
-
Shaik NF, Saherwala AA, Tzeng DL. Gender Parity in Authorship of Published Randomized Clinical Trials in Stroke Neurology From 2000 to 2021. JAMA Netw Open. 2022 03 01; 5(3):e222423.
-
Ashina M, Goadsby PJ, Dodick DW, Tepper SJ, Xue F, Zhang F, Brennan F, Paiva da Silva Lima G. Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials. JAMA Neurol. 2022 02 01; 79(2):159-168.
-
Sasongko TH, Nagalla S. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Cochrane Database Syst Rev. 2021 12 21; 12:CD009191.
-
Ho AY, Tabrizi S, Dunn SA, McArthur HL. Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer. Breast Cancer Res Treat. 2022 Jan; 191(2):229-241.